Skip to content
Does Ashwagandha Actually Work? What 6 Clinical Trials Found
Supplements

Does Ashwagandha Actually Work? What 6 Clinical Trials Found

Evidence Explainer
8 min read

Does Ashwagandha Actually Work? What 6 Clinical Trials Found

Direct Answer: Yes — ashwagandha has meaningful clinical evidence for reducing cortisol and anxiety in healthy stressed adults, though the effect size varies by extract type and duration. A 2022 meta-analysis (Priyanka et al., PMID: 36017529) found significant anxiety reductions (SMD: -1.55) and stress reductions (SMD: -1.75) vs. placebo across RCTs. A 2024 meta-analysis (PMID: 40746175) confirmed consistent cortisol reductions but found pooled perceived stress improvements were not statistically significant — suggesting cortisol biomarker response may precede or dissociate from subjective stress relief. The evidence is strongest for standardized extracts (KSM-66, Sensoril) at 300–600 mg/day over 8–12 weeks.

TL;DR

  • Cortisol: Significant reductions confirmed in multiple RCTs and two meta-analyses
  • Anxiety/Stress: Significant in individual trials; pooled meta-analysis result is mixed
  • Cognition: RCT evidence for improved memory, attention, and processing speed at 8 weeks
  • Sleep: RCT evidence for improved sleep quality, particularly at Sensoril doses
  • Best Extract: KSM-66 (most studied), Sensoril (stress + sleep), Shoden (high-potency)
  • Evidence Verdict: Promising and real — not hype, but not a cure-all

What Is Ashwagandha?

Ashwagandha (Withania somnifera) is an Ayurvedic adaptogenic herb native to India and North Africa. In traditional medicine, it has been used for over 3,000 years as a general tonic and stress-reducing agent. The plant’s root contains active compounds called withanolides — steroidal lactones believed to be responsible for its effects on the stress response.

As an adaptogen, ashwagandha does not force a specific pharmacological response; it is thought to help the body maintain homeostasis under stress. This makes it qualitatively different from stimulants or sedatives, both of which produce strong directional effects.

Modern research has focused on ashwagandha’s interaction with the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal cascade that governs the cortisol stress response. Whether this mechanism translates into clinically meaningful benefits is exactly what the RCT record shows.


What the Clinical Trials Show

Cortisol and Stress: The Core Evidence

The most robust single trial remains Chandrasekhar et al., 2012 (PMID: 23439798) — a prospective, double-blind, placebo-controlled study of 300 mg KSM-66 twice daily (600 mg/day) for 60 days in 64 adults with chronic stress. Results:

  • Serum cortisol: reduced by 27.9% vs. placebo (p = 0.0006)
  • Perceived Stress Scale: significant improvements on all subscales
  • Well-being, energy, and sleep quality also significantly improved

This remains one of the most cited ashwagandha studies and established the 600 mg/day KSM-66 dose as a benchmark.

Salve et al., 2019 (PMID: 31517876) replicated and extended this with 240 mg Shoden ashwagandha (a higher-potency extract at 35% withanolide glycosides) for 60 days, finding significant improvements in cortisol (morning and evening), anxiety, and overall stress versus placebo.

Ambiye et al., 2023 (PMID: 37832082) — a double-blind RCT of standardized ashwagandha root extract for 60 days — found significant reductions in perceived stress scale scores (38.6–41.6% from baseline) alongside cortisol modulation and improved sleep.

What Does the Meta-Analysis Say?

Priyanka et al., 2022 (PMID: 36017529) pooled data from multiple ashwagandha RCTs in a systematic review and meta-analysis, finding:

  • Anxiety: significant reduction (SMD: -1.55)
  • Stress level: significant reduction (SMD: -1.75)

However, a more recent and comprehensive 2024 meta-analysis (PMID: 40746175) — which searched databases from 2012 to 2024 — found a different picture when it came to perceived stress:

  • Cortisol: significant reduction confirmed across studies
  • Perceived stress (PSS scores): not statistically significant when pooled (SMD = -0.355, 95% CI: -1.188 to 0.47; p = 0.40)

The 2024 analysis highlights a meaningful dissociation: objective cortisol reduction is well-supported, but whether this translates to subjectively felt stress relief may depend on population, extract standardization, and study duration. This does not mean ashwagandha is ineffective — it means the question “does it work?” depends on what outcome you are measuring.

Cognition: Emerging Evidence

Deshpande et al., 2021 (PMID: 34858513) — a randomized, double-blind, placebo-controlled 8-week trial — found ashwagandha supplementation significantly improved:

  • Immediate and general memory
  • Executive function
  • Sustained attention
  • Processing speed

This was in healthy, stressed adults (not dementia patients), suggesting ashwagandha may reduce the cognitive toll of chronic stress.

Sleep Quality

Several trials document sleep improvements as a secondary outcome. The 2023 Ambiye trial (PMID: 37832082) found significant improvements in sleep quality measures alongside stress and cortisol benefits. The effect is likely mediated through cortisol reduction (lower evening cortisol supports sleep onset) and triethylene glycol content in ashwagandha leaf, which has independent sedative properties.


What Ashwagandha Does NOT Do

Being honest about what the evidence does not support:

  • It is not an acute anxiolytic. Ashwagandha does not work like benzodiazepines or fast-acting supplements. Effects build over weeks.
  • It is not a testosterone booster for healthy young men at standard doses. Some trials show modest testosterone support in men with subfertility or extreme stress; the effect in healthy eugonadal men is inconsistent and small.
  • It does not cure clinical anxiety disorders. RCT populations are generally healthy stressed adults, not those with GAD, PTSD, or panic disorder.
  • It does not produce universal stress relief. The 2024 meta-analysis found pooled perceived stress improvement was not statistically significant. Individual response varies.

Who Should Consider Ashwagandha?

Good candidates:

  • Healthy adults with chronic moderate-to-high stress wanting cortisol modulation
  • People with stress-related sleep difficulties (prolonged sleep onset, poor sleep quality)
  • People noticing stress-related cognitive slowing (memory, concentration)
  • Athletes looking to manage cortisol from heavy training

Who should proceed with caution:

  • People with thyroid disorders (ashwagandha may increase thyroid hormone levels)
  • Those with autoimmune conditions (adaptogenic immune effects are unclear)
  • Pregnant or breastfeeding individuals
  • Anyone with liver conditions (rare but documented hepatotoxicity case reports exist)
  • People on sedatives, thyroid medications, or immunosuppressants

Choosing the Right Ashwagandha Supplement

The extract matters significantly. Unstandardized root powder has a weaker and less consistent evidence base. Look for:

ExtractWithanolide %Best Evidence For
KSM-665% (root only)Stress, cortisol, athletic performance
Sensoril10% (root + leaf)Stress, sleep
Shoden35% (glycosides)Potent dose efficiency
Generic root powderUnstandardizedWeakest evidence

Well-studied product options:

  • Jarrow Formulas Ashwagandha KSM-66 (300 mg): uses the most-studied extract form; two capsules reach the 600 mg/day trial dose. Check price on Amazon →
  • Thorne Botanicals Ashwagandha (KSM-66, 300 mg): third-party tested, NSF-certified facility; Thorne’s quality assurance is among the highest in the industry. Check price on Amazon →
  • NOW Foods Ashwagandha (KSM-66, 300 mg): NSF facility certified, good value option; widely available. Check price on Amazon →

How We Score: G6 Evidence Quality for Ashwagandha

Evidence-explainer articles on Body Science Review apply our G6 weighted framework to rate the overall strength of evidence for the primary claims examined — rather than scoring individual products. For this article, we scored the evidence quality for ashwagandha’s effects on cortisol, stress, anxiety, and cognition in healthy adults.

The G6 framework applies these weights (30/25/20/15/10):

  • Research Quality (30%): Number of independent RCTs, effect sizes, replication across labs, and methodological rigor.
  • Evidence Quality (25%): Peer-review status, journal quality, and whether findings are consistent across systematic reviews and meta-analyses.
  • Value (20%): How accessible, affordable, and practical the intervention is for most readers.
  • Population Relevance (15%): Whether the studied populations (healthy stressed adults) match the target readership.
  • Transparency (10%): Whether study funding, conflicts of interest, and limitations are disclosed in the literature.
ClaimResearch QualityEvidence QualityValuePopulation RelevanceTransparencyG6
Cortisol reduction9.08.59.59.07.58.8
Perceived stress reduction7.57.09.59.07.07.9
Anxiety reduction8.08.09.58.57.58.3
Cognitive function7.07.59.58.57.57.8
Sleep quality7.07.09.58.57.07.7

Score notes: Cortisol reduction earns the highest composite (8.8) because it has consistent, replicated findings across independent RCTs and is confirmed by two separate meta-analyses. Perceived stress reduction scores lower (7.9) because the most comprehensive 2024 meta-analysis found pooled perceived stress improvement was not statistically significant — meaningful heterogeneity exists. Cognitive function earns 7.8 — the evidence is growing but based on fewer independent trials than the cortisol endpoint.

Overall G6 evidence verdict for ashwagandha: Strong evidence for cortisol reduction and anxiety improvement; moderate evidence for perceived stress, cognition, and sleep. Standardized extracts (KSM-66, Sensoril) at clinical doses for 8–12 weeks are the evidence-backed protocol.


The Bottom Line: Does Ashwagandha Work?

The honest answer is: yes, with caveats.

For cortisol reduction, the evidence is consistent and meaningful — multiple double-blind RCTs and meta-analyses confirm this. For perceived stress and anxiety, most individual trials are positive, though one comprehensive 2024 meta-analysis found the pooled effect on subjective stress scales did not reach statistical significance.

What this means practically: ashwagandha is likely to produce measurable cortisol reductions and may reduce the subjective experience of stress, particularly with KSM-66 or Sensoril extracts at 300–600 mg/day over 8–12 weeks. Individual responses vary.

It is not a miracle adaptogen, but it is one of the most evidence-backed supplements in the stress/cortisol category — a rare combination in a market full of overhyped herbs.

Takeaway: If you experience chronic stress with elevated cortisol, disrupted sleep, or cognitive fog, a 12-week trial of a standardized ashwagandha extract is supported by the clinical evidence.


Frequently Asked Questions

How long does ashwagandha take to work?

Most clinical trials document significant effects at 8–12 weeks of daily use. A 2023 RCT (Ambiye et al., PMID: 37832082) found significant improvements in perceived stress and cortisol at the 60-day mark. Some users report subjective improvements in sleep quality and anxiety within 2–4 weeks, but the most reliable cortisol and stress-scale changes emerge after consistent use for at least 8 weeks.

Does ashwagandha actually lower cortisol?

Yes — cortisol reduction is the most consistently supported effect in the clinical literature. A 2024 systematic review and meta-analysis (PMID: 40746175) found significant reductions in cortisol across multiple RCTs, though the same review noted that perceived stress scores did not show statistically significant improvement when pooled. The 2012 Chandrasekhar RCT (PMID: 23439798) found a 27.9% reduction in serum cortisol with KSM-66 at 600 mg/day over 60 days.

What is the best form of ashwagandha?

KSM-66 and Sensoril are the two most clinically studied ashwagandha extracts. KSM-66 (5% withanolides from root only) has the broadest evidence base for stress, cortisol, and athletic performance. Sensoril (10% withanolides, root and leaf) is studied primarily for stress and sleep. Both outperform unstandardized ashwagandha root powder significantly.

Does ashwagandha work for anxiety?

A 2022 systematic review and meta-analysis (Priyanka et al., PMID: 36017529) found significant anxiety reductions (SMD: -1.55 vs. placebo). Individual trials consistently show improvements on validated anxiety scales at 8–12 weeks. The effect appears strongest for generalized, stress-related anxiety in otherwise healthy adults.

Is ashwagandha safe to take long-term?

Most RCTs run 8–12 weeks, and ashwagandha is generally well tolerated in that window. Long-term safety data beyond 6 months is limited. Rare hepatotoxicity case reports exist; consult a physician if you have liver conditions, thyroid disorders, or autoimmune disease. For otherwise healthy adults, a 3–6 month cycle with breaks is a conservative approach pending long-term safety data.

Frequently Asked Questions

BS
Researched by Body Science Review Editorial Research Team

Content on Body Science Review is grounded in peer-reviewed evidence from PubMed, Examine.com, and Cochrane reviews, produced to our published editorial standards. See our methodology at /how-we-test.